Thermo Fisher Scientific Repayments of Long-Term Debt increased by 68.5% to $1.41B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 68.5%, from $838.00M to $1.41B.
Higher repayments indicate a focus on reducing leverage and interest expense, while lower repayments may suggest a preference for maintaining debt levels or prioritizing other capital uses.
Cash outflows used to pay down the principal amount of long-term debt obligations. This reflects the company's commitmen...
Standard financing activity metric for companies with debt obligations.
other_repayments_of_long_term_debt| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00M | $2.00M | $375.00M | $0.00 | $0.00 | $0.00 | $1.00B | $1.00B | $838.00M | $1.41B |
| QoQ Change | — | +100.0% | >999% | -100.0% | — | — | — | +0.0% | -16.2% | +68.5% |
| YoY Change | — | — | — | -100.0% | -100.0% | -100.0% | — | — | — | +68.5% |